Abstract
Helicobacter pylori (H. pylori) infects the stomach of more than 50% of humans and causes chronic gastritis in most infected individuals. H. pylori has developed mechanisms to survive the harsh gastric environment. In the host infected with H. pylori, various immune cells infiltrate into the infected gastric mucosa and then severe inflammatory responses occur. This severe inflammation, however, is not able to clear H. pylori and the process may contribute to the associated disease pathogenesis. Toll-like receptor 2 (TLR2) and Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) might be essential for activation of innate immunity against H. pylori infections. Type 1 helper T cells and regulatory T cells induced in stomach and Peyers patches play an important role in the associated chronic inflammation. Recently, vaccines targeting various factors associated with H. pylori infection have been developed. This review provides information on the mechanisms of the host immune system response against H. pylori infections and the characteristics of H. pylori that enable it to evade host defenses.
Keywords: Gastritis, Helicobacter pylori, immunity, inflammation, Peyer's patch, vaccine
Current Chemical Biology
Title: Mucosal Immune Regulation and Vaccines for Helicobacter-associated Gastritis
Volume: 4 Issue: 3
Author(s): Yasuhisa Ano, Hirokazu Tsubone, Akikazu Sakudo and Daisuke Fujiwara
Affiliation:
Keywords: Gastritis, Helicobacter pylori, immunity, inflammation, Peyer's patch, vaccine
Abstract: Helicobacter pylori (H. pylori) infects the stomach of more than 50% of humans and causes chronic gastritis in most infected individuals. H. pylori has developed mechanisms to survive the harsh gastric environment. In the host infected with H. pylori, various immune cells infiltrate into the infected gastric mucosa and then severe inflammatory responses occur. This severe inflammation, however, is not able to clear H. pylori and the process may contribute to the associated disease pathogenesis. Toll-like receptor 2 (TLR2) and Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) might be essential for activation of innate immunity against H. pylori infections. Type 1 helper T cells and regulatory T cells induced in stomach and Peyers patches play an important role in the associated chronic inflammation. Recently, vaccines targeting various factors associated with H. pylori infection have been developed. This review provides information on the mechanisms of the host immune system response against H. pylori infections and the characteristics of H. pylori that enable it to evade host defenses.
Export Options
About this article
Cite this article as:
Ano Yasuhisa, Tsubone Hirokazu, Sakudo Akikazu and Fujiwara Daisuke, Mucosal Immune Regulation and Vaccines for Helicobacter-associated Gastritis, Current Chemical Biology 2010; 4 (3) . https://dx.doi.org/10.2174/2212796811004030219
DOI https://dx.doi.org/10.2174/2212796811004030219 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of ACT on Self-Esteem and Self-efficacy of Women with Breast Cancer in Iran
Current Women`s Health Reviews Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications
Current Drug Delivery Molecular Determinants of Gastrointestinal and Liver Cancers: Role of Bile Acid Activated Nuclear Receptors
Current Topics in Medicinal Chemistry Mucoadhesive Polymers for Delivery of Drugs to the Oral Cavity
Recent Patents on Drug Delivery & Formulation LncRNA as a Therapeutic Target for Angiogenesis
Current Topics in Medicinal Chemistry Pathophysiological Role of Hepatocyte Nuclear Factor 6 in Negative Regulation of Hepatic Apoptosis: A Novel Hypothesis
Current Molecular Medicine Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters Chirality - A New Era of Therapeutics
Mini-Reviews in Medicinal Chemistry Prospects of Nanocarriers for Oral Delivery of Bioactives Using Targeting Strategies
Current Pharmaceutical Biotechnology Meet Our Editor:
Current Enzyme Inhibition Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2
Current Neurovascular Research Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors
Recent Patents on Anti-Cancer Drug Discovery Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Recent Patents on Anti-Cancer Drug Discovery Tissue Fatty Acid Profile is Differently Modulated from Olive Oil and Omega-3 Polyunsaturated Fatty Acids in ApcMin/+ Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Current Medicinal Chemistry - Anti-Cancer Agents DNA Repair Inhibitors: The Next Major Step to Improve Cancer Therapy
Current Topics in Medicinal Chemistry Molecular Targeting of Lymphatics for Therapy
Current Pharmaceutical Design Mucoadhesive Low Molecular Chitosan Complexes to Protect rHuKGF from Proteolysis: <i>In-vitro</i> Characterization and FHs 74 Int Cell Proliferation Studies
Current Pharmaceutical Biotechnology